245 related articles for article (PubMed ID: 37311018)
1. Engineered Polyethylene Glycol-Coated Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent.
Dabagh S; Haris SA; Ertas YN
ACS Biomater Sci Eng; 2023 Jul; 9(7):4138-4148. PubMed ID: 37311018
[TBL] [Abstract][Full Text] [Related]
2. Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.
Chaudhary R; Roy K; Kanwar RK; Walder K; Kanwar JR
J Nanobiotechnology; 2016 Jan; 14():6. PubMed ID: 26775253
[TBL] [Abstract][Full Text] [Related]
3. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells.
Sobhani T; Shahbazi-Gahrouei D; Rostami M; Zahraei M; Farzadniya A
J Med Signals Sens; 2019; 9(4):245-251. PubMed ID: 31737553
[TBL] [Abstract][Full Text] [Related]
5. Novel MR imaging nanoprobe for hepatocellular carcinoma detection based on manganese-zinc ferrite nanoparticles: in vitro and in vivo assessments.
Sobhani T; Shahbazi-Gahrouei D; Zahraei M; Hejazi SH; Dousti F; Rostami M
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4939-4957. PubMed ID: 36309602
[TBL] [Abstract][Full Text] [Related]
6. Dextrin-coated zinc substituted cobalt-ferrite nanoparticles as an MRI contrast agent: In vitro and in vivo imaging studies.
Sattarahmady N; Zare T; Mehdizadeh AR; Azarpira N; Heidari M; Lotfi M; Heli H
Colloids Surf B Biointerfaces; 2015 May; 129():15-20. PubMed ID: 25819361
[TBL] [Abstract][Full Text] [Related]
7. PEG coating reduces NMR relaxivity of Mn(0.5)Zn(0.5)Gd(0.02)Fe(1.98)O4 hyperthermia nanoparticles.
Issa B; Qadri S; Obaidat IM; Bowtell RW; Haik Y
J Magn Reson Imaging; 2011 Nov; 34(5):1192-8. PubMed ID: 21928382
[TBL] [Abstract][Full Text] [Related]
8. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
9. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
[TBL] [Abstract][Full Text] [Related]
10. Engineered Theranostic Magnetic Nanostructures: Role of Composition and Surface Coating on Magnetic Resonance Imaging Contrast and Thermal Activation.
Nandwana V; Ryoo SR; Kanthala S; De M; Chou SS; Prasad PV; Dravid VP
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6953-61. PubMed ID: 26936392
[TBL] [Abstract][Full Text] [Related]
11. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
Li X; Xia S; Zhou W; Ji R; Zhan W
Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of polyethylene glycol (PEG) coated Fe3O4 nanoparticles by chemical co-precipitation method for biomedical applications.
Anbarasu M; Anandan M; Chinnasamy E; Gopinath V; Balamurugan K
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():536-9. PubMed ID: 25123943
[TBL] [Abstract][Full Text] [Related]
13. High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics.
Sun Y; Yan C; Xie J; Yan D; Hu K; Huang S; Liu J; Zhang Y; Gu N; Xiong F
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29536-29548. PubMed ID: 31333014
[TBL] [Abstract][Full Text] [Related]
14. Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic Fe
Hoque SM; Huang Y; Cocco E; Maritim S; Santin AD; Shapiro EM; Coman D; Hyder F
Contrast Media Mol Imaging; 2016 Nov; 11(6):514-526. PubMed ID: 27659164
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.
Yue-Jian C; Juan T; Fei X; Jia-Bi Z; Ning G; Yi-Hua Z; Ye D; Liang G
Drug Dev Ind Pharm; 2010 Oct; 36(10):1235-44. PubMed ID: 20818962
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review on the applications of ferrite nanoparticles in the diagnosis and treatment of breast cancer.
Akhtar MF; Afzaal A; Saleem A; Roheel A; Khan MI; Imran M
Med Oncol; 2024 Jan; 41(2):53. PubMed ID: 38198041
[TBL] [Abstract][Full Text] [Related]
17. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide.
Ebadi M; Saifullah B; Buskaran K; Hussein MZ; Fakurazi S
Int J Nanomedicine; 2019; 14():6661-6678. PubMed ID: 31695362
[TBL] [Abstract][Full Text] [Related]
19. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Characterization, and Cytotoxicity Evaluation of Polyethylene Glycol-Coated Iron Oxide Nanoparticles for Radiotherapy Application.
Anuje M; Pawaskar PN; Khot V; Sivan A; Jadhav S; Meshram J; Thombare B
J Med Phys; 2021; 46(3):154-161. PubMed ID: 34703099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
